Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 224394
                    [Title] => Study halted to announce positive results of breast cancer treatment
                    [Summary] => The study showed breast cancer patients who follow up five years of tamoxifen treatment with letrozole, an estrogen suppressor, cut the risk of recurrence by nearly half.


TORONTO (AP) – Researchers were so encouraged by early results from a study on preventing breast cancer recurrence that they halted their work so more women can benefit from the findings.


                    [DatePublished] => 2003-10-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

KATHY ANDERSON

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 224394
                    [Title] => Study halted to announce positive results of breast cancer treatment
                    [Summary] => The study showed breast cancer patients who follow up five years of tamoxifen treatment with letrozole, an estrogen suppressor, cut the risk of recurrence by nearly half.


TORONTO (AP) – Researchers were so encouraged by early results from a study on preventing breast cancer recurrence that they halted their work so more women can benefit from the findings.


                    [DatePublished] => 2003-10-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Study halted to announce positive results of breast cancer treatment

October 16, 2003 - 12:00am

The study showed breast cancer patients who follow up five years of tamoxifen treatment with letrozole, an estrogen suppressor, cut the risk of recurrence by nearly half. TORONTO (AP) – Researchers were so...

Science and Environment